UTHR FY 2016 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

UTHRUnited Therapeutics Corporation

$24B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.6B+9.1% YoY

Gross Profit

$1.5B95.5% margin

Operating Income

$1.1B66.4% margin

Net Income

$714M44.6% margin

EPS (Diluted)

$15.25

Cash Flow

Operating Cash Flow

$644M

Free Cash Flow

$600M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$2.3B

Total Liabilities

$463M

Stockholders' Equity

$1.9B

Cash & Equivalents

$1.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$1.5B	+9.1%
Gross Profit	$1.5B	$1.4B	+9.3%
Operating Income	$1.1B	$699M	+51.9%
Net Income	$714M	$652M	+9.5%